- Recommend one FDA-approved drug, one off-label drug, and one nonpharmacological intervention for treating neuro cognitive disorder in pregnant women.
- Explain the risk assessment you would use to inform your treatment decision making. What are the risks and benefits of the FDA-approved medicine? What are the risks and benefits of the off-label drug?
- Explain whether clinical practice guidelines exist for this disorder, and if so, use them to justify your recommendations. If not, explain what information you would need to take into consideration.
- Support your reasoning with at least three current, credible scholarly resources, one each on the FDA-approved drug, the off-label, and a nonpharmacological intervention for the disorder.
Section One Ethics ProblemsFrom Thiroux and Krasnow’s Ethics: Theory and Practice 11th Edition
Section One Ethics Problems From Thiroux and Krasnow’s Ethics: Theory and Practice 11th Edition Choose ONE of the following Ethics Problems and answer it to the very best of your ability. These questions are fairly complex, and will require a minimum of 4 full pages (double spaced, not including the